78
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis

, , , &
Pages 457-468 | Published online: 07 May 2014

References

  • RestrepoMIMortensenEMPughJAAnzuetoACOPD is associated with increased mortality in patients with community-acquired pneumoniaEur Respir J200628234635116611653
  • MüllerovaHChigboCHaganGWThe natural history of community-acquired pneumonia in COPD patients: a population database analysisRespir Med201210681124113322621820
  • NanniniLJPoolePMilanSJKestertonACombined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20138CD00682623990350
  • BarnesNCQiuYSPavordIDAntiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung diseaseAm J Respir Crit Care Med2006173773674316424444
  • DransfieldMTBourbeauJJonesPWOnce-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trialsLancet Respir Med20131321022324429127
  • BREO™ ELLIPTA™ (fluticasone furoate/vilanterol inhalation powder) for treatment of chronic obstructive pulmonary disease. NDA204275 Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM347931.pdfAccessed January 6, 2014
  • CelliBRMacNeeWATS/ERS Task ForceStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
  • BreimanLClassification and Regression TreesNew York, NY, USAChapman and Hall1983
  • TherneauTAtkinsonBRipleyBRPART: Recursive Partitioning. R package version 4.0-12012 Available from: http://cran.r-project.org/web/packages/rpart/index.htmlAccessed January 6, 2014
  • VanfleterenLESpruitMAGroenenMClusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187772873523392440
  • CrimCCalverleyPMAndersonJAPneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study resultsEur Respir J200934364164719443528
  • SinghSLokeYKRisk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: a critical review and updateCurr Opin Pulm Med201016211812219926996
  • HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
  • KnolWvan MarumRJJansenPASouvereinPCSchobbenAFEgbertsACAntipsychotic drug use and risk of pneumonia in elderly peopleJ Am Geriatr Soc200856466166618266664
  • SeminogOOGoldacreMJRisk of pneumonia and pneumococcal disease in people with severe mental illness: English record linkage studiesThorax201368217117623242947
  • ChouFHTsaiKYChouYMThe incidence and all-cause mortality of pneumonia in patients with schizophrenia: a nine-year follow-up studyJ Psychiatr Res201347446014623317876
  • QuintJKBrownJSWeighing up risk factors for pneumonia: the role of mental illness and benzodiazepine useThorax201368212112223250999
  • HananiaNAMüllerovaHLocantoreNWDeterminants of depression in the ECLIPSE chronic obstructive pulmonary disease cohortAm J Respir Crit Care Med2011183560461120889909
  • PapaioannouAIBartziokasKTsikrikaSThe impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbationsEur Respir J201341481582322878874
  • RushnakMJLeevyCMEffect of diazepam on the lower esophageal sphincter. A double-blind controlled studyAm J Gastroenterol19807321271307395839
  • VozorisNTFischerHDWangXAndersonGMBenzodiazepine use among older adults with chronic obstructive pulmonary disease: a population-based cohort studyDrugs Aging201330318319223371396
  • ObioraEHubbardRSandersRDMylesPRThe impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: a nested case-control and survival analysis in a population-based cohortThorax201368216317023220867
  • DublinSWalkerRLJacksonMLUse of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control studyJ Am Geriatr Soc201159101899190722091503
  • SandersRDDegosVYoungWLCerebral perfusion under pressure: is the autoregulatory ‘plateau’ a level playing field for all?Anaesthesia2011661196897221933160
  • VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
  • Centers for Disease Control and PreventionAdvisory Committee on Immunization Practices recommended immunization schedules for persons aged 0 through 18 years and adults aged 19 years and older – United States, 2013MMWR Surveill Summ201362Suppl 11
  • WeatherallMShirtcliffePTraversJBeasleyRUse of cluster analysis to define COPD phenotypesEur Respir J201036347247420930198
  • TraversJWeatherallMFingletonJBeasleyRTowards individualised medicine for airways disease: identifying clinical phenotype groupsEur Respir J20123941033103422467724
  • BurgelPRRocheNPaillasseurJLClinical COPD phenotypes identified by cluster analysis: validation with mortalityEur Respir J201240249549622855468
  • Garcia-AymerichJGómezFPBenetMIdentification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypesThorax201166543043721177668
  • LokeYKKwokCSNirubanAMyintPKValue of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysisThorax2010651088489020729235